[Non invasive markers using for the assessment of fibrosis in hepatitis C]

Archive ouverte

Zarski, Jean-Pierre | Bedossa, Pierre | Bronowicki, Jean-Pierre | Doffoel, Michel | Poynard, Thierry

Edité par CCSD ; Elsevier Masson -

International audience. Non invasive fibrosis markers, recently developed, are now an interesting alternative to liver biopsy in order to appreciate the severity of chronic hepatitis C. Serological markers, especially Fibrotest and Fibrometer, have a good diagnostic accuracy to discriminate patients with mild fibrosis to those with severe fibrosis. For intermediate stages, the discordance is very important and often justifies liver biopsy or using of several markers. Transient elastography (Fibroscan) is a new non invasive method subject to good conditions of utilisation. Diagnostic accuracy is improved by the using of all the markers, especially of Fibrotest. Transient elastography is also a promising method for assessing the severity of cirrhosis.

Consulter en ligne

Suggestions

Du même auteur

[Hepatitis C, cirrhosis and hepatocellular carcinoma]

Archive ouverte | Zarski, Jean-Pierre | CCSD

International audience. The screening for the detection of hepatocellular carcinoma is based on ultrasound sonography which should be realised in patients with post-hepatitis C cirrhosis with a delay between 3 and 6...

[The patient with uncontrolled chronic hepatitis B]

Archive ouverte | Zarski, Jean-Pierre | CCSD

International audience. The treatment of chronic hepatitis B is now based on the using of pegylated interferon or nucleoside or nucleotide analogs. In the majority of cases, these drugs can control viral replication...

Ideal oral combinations to eradicate HCV: The role of ribavirin

Archive ouverte | Hézode, Christophe | CCSD

International audience. Current all-oral interferon-free regimens offer sustained virological response (SVR) rates above 90% as well as 12-week treatment durations for the majority of patients with chronic hepatitis...

Chargement des enrichissements...